Filing Flows › Selectis Health (GBCS) › Q4 2025
Selectis Health (GBCS) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Apr 15, 2026
Selectis Health (GBCS) reported revenue of $9.7M for the fourth quarter 2025 (Q4 2025), -7% from a year earlier and -11% from the quarter before. Operating margin was -4.1%, net loss $804K (8.3% of revenue).
Selectis Health, Q4 2025: revenue $9.7M (-7% year over year), operating margin -4.1%, net loss $804K, operating cash flow $644K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | -11% | -7% |
| Operating profit | −$396K | — | — |
| Net earnings | −$804K | -207% | — |
| Operating cash flow | $644K | +130% | — |
| Free cash flow | $587K | +113% | — |
What changed
Revenue was $9.7M in Q4 2025, down 7% year over year and down 11% from the previous quarter.
Operating costs exceeded revenue by $396K, an operating margin of -4.1%. Total costs fell 4% while revenue fell 7%. The quarter ended with a net loss of $804K, after a profit of $752K the previous quarter. Net interest and other expense of $408K was the main reason.
Operating cash flow was $644K. Non-cash charges added back $384K of depreciation and amortization. Working capital and other items added $1.1M. Capital expenditures of $57K left free cash flow of $587K.
Questions
What was Selectis Health's revenue in the fourth quarter 2025?
Selectis Health (GBCS) reported revenue of $9.7M for the fourth quarter 2025 (Q4 2025), -7% from a year earlier and -11% from the quarter before.
Was Selectis Health profitable in the fourth quarter 2025?
Operating loss was $396K (-4.1% of revenue) and net loss $804K.
Source: Selectis Health 10-K on SEC EDGAR.